Higher predisposition to adverse effects Additionally, people who had previously used gastrointestinal medications -- which may indicate they are more vulnerable to the common adverse gastrointestinal side-effects reported by GLP1-RA users, such as nausea, vomiting, diarrhea -- were 9% more likely to discontinue semaglutide within the first year
About 1 out of every 3 patients lost 20% or more of their weight
After week 16, weight loss continues but at a slower pace as your body reaches a new metabolic baseline
Patients taking Zepbound should maintain regular follow-up with their healthcare provider to monitor treatment efficacy, tolerability, and potential complications
And so I might just like titrate somebody up on the tiniest amount of thyroid where most doctors would be like, well, thats not enough to do anything